PLEASANTON, Calif., Nov. 2, 2021 /PRNewswire/ — Veeva Systems (NYSE: VEEV) will announce financial results for its third fiscal quarter, which ended October 31, 2021, after market close on December 1, 2021. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results.
Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event.
Event: |
Veeva’s Fiscal 2022 Third Quarter Results Conference Call |
Date: |
Wednesday, December 1, 2021 |
Time: |
2:00 p.m. PT (5:00 p.m. ET) |
Online Registration: www.directeventreg.com |
|
Conference ID: 6998914 |
|
Webcast: |
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor our investor relations website in addition to following our press releases, SEC filings, and public conference calls and webcasts.
Investor Relations Contact:
Ato Garrett
Veeva Systems
925-452-6500
ir@veeva.com
Media Contact:
Deivis Mercado
Veeva Systems
925-226-8821
pr@veeva.com
View original content:https://www.prnewswire.com/news-releases/veeva-to-release-fiscal-2022-third-quarter-results-on-december-1-2021-301414775.html
SOURCE Veeva Systems
- Leading efficient care management for the elderly with unimpeded smartcare https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png SEOUL, South Korea, Nov.…
- Attruby is the first and only approved product with aspecifying near-complete stabilization…
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
NEW YORK, Nov. 22, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape -…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…